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Sir: We have read with great interest the correspondence by Dr Crotty1 and colleagues on the use of 
XIST chromogenic in situ hybridization for sex determination in the context of presumed tissue 
misidentification. 
The authors refer to H3K27me3 immunostaining which has been reported to label the inactivated X 
chromosome2 and therefore may serve the same purpose as XIST ISH, i.e. an in situ analysis of sex. 
The mentioned study by Dr Schaefer and colleagues beautifully describes the morphological 
phenomenon and discusses the underlying biology, but does not formally assess the applicability of 
H3K27me3 immunostaining for sex determination in a routine setting. We have therefore sought to 
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close this gap by analysing a variety of neoplastic and non-neoplastic tissues (Table 1) in a blinded 
fashion. H3K27me3 immunohistochemistry was performed on a Leica Bond III immunostainer with a 
rabbit monoclonal antibody (clone C36B11; Cell Signalling; at 1:200 dilution with EDTA-based 
antigen retrieval). Given that in the context of presumed misidentification the tissue fragments of 
interest are usually small, we included full histological slides and tissue microarrays (TMA; 600 µm 
core diameter) of the same neoplastic and non-neoplastic tissue types.  
Sex prediction was correct in all 60 non-neoplastic tissues (full slides and TMA cores), in all 34 TMA 
glioma samples and in 64 out of 65 full slides from gliomas. The only tumour for which sex was not 
predicted correctly derived from a female patient and lacked Barr body staining both in tumour cells 
and non-neoplastic cells. Actual tissue misidentification in this case could be ruled out as 
microsatellite analysis had been performed in order to test for 1p19q co-deletion.  
In sum, H3K27me3 immunohistochemistry predicted sex accurately in 158 out of 159 (99.37%; 95% 
confidence interval by the modified Wald method: 0.9617 to >0.9999%) which is not significantly 
different (p=1.0000 by Fisher’s exact test) from the results reported by Dr Crotty and colleagues for 
XIST ISH (268 out of 268; 100; 95% confidence interval: 0.9830 to 1.0000). In the vast majority of 
samples, sex determination was very straightforward and assessed correctly within seconds. In 
particular, in many female tissues the presence of Barr body-pattern staining was obvious already at 
medium-power magnification. In more challenging cases we found the following features useful to 
distinguish true Barr bodies from non-specific chromatin condensations: Barr bodies were usually 
single per nucleus, well-defined, predominantly near to the nuclear membrane, easiest to identify in 
cells which lacked any other non-specific staining and present in a higher proportion of cells (Figure 
1). 
We conclude that H3K27me3 immunostaining can predict sex with high accuracy in both neoplastic 
and non-neoplastic tissues. Because of its potential in the diagnosis of malignant peripheral nerve 
sheath tumour3, 4 it will likely be increasingly used in diagnostic routine across pathology 
departments in the future. 
Easy availability, cost-effectiveness and rapid turnaround lower the threshold to enter a process of 
tissue identity analysis. They are therefore critical for its widespread use – and thereby ultimately for 
patient security – in the context of presumed tissue misidentification. We believe that H3K27me3 
immunostaining for sex determination fulfils all of these requirements. Furthermore, it offers the 
advantage of an internal positive control, which may be critical in small tissue fragments of uncertain 
preservation. 
In a broader perspective, we are convinced that a comprehensive approach to tissue 
misidentification is required: We need to prevent misidentification (i.e. primary prevention in 
preventive medicine terminology) by appropriate organizational measures at the pre-analytical and 
analytical level, but also (in the sense of secondary prevention) to have an armamentarium of 
methods at hand that allows detection of tissue misidentification in a whole variety of scenarios. 
Such a comprehensive approach will have to include in-situ techniques (of which XIST-ISH and 
H3K27me3 are promising candidates) to optimally serve patient security. 
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Table 
 
 Male Female 
Normal autopsy tissue – whole slide 19 11 
Normal patient tissue – TMA 18 12 
Neoplastic – Whole slide (glioma) 39 26 
Neoplastic – Tissue microarray (diffuse glioma) 15 19 
Table 1. Overview of tissues analysed by H3K27me3 immunostaining for sex determination. Autopsy 
tissue included heart, lung, thyroid, liver, spleen, brain, skeletal muscle and skin. 
 
 
Figure legend 
Figure 1. Representative photomicrographs of H3K27me3 stained slides from gliomas of a male (A) 
and a female (B) patient. Original magnification: 630x 
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